SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011091
Filing Date
2018-08-07
Accepted
2018-08-07 16:57:36
Documents
33
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 350101
2 ex31-1.htm EX-31.1 18432
3 ex31-2.htm EX-31.2 18607
4 ex32.htm EX-32 8266
  Complete submission text file 0001493152-18-011091.txt   1346568

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pvct-20180630.xml EX-101.INS 99010
6 XBRL SCHEMA FILE pvct-20180630.xsd EX-101.SCH 18242
7 XBRL CALCULATION FILE pvct-20180630_cal.xml EX-101.CAL 25786
8 XBRL DEFINITION FILE pvct-20180630_def.xml EX-101.DEF 66982
9 XBRL LABEL FILE pvct-20180630_lab.xml EX-101.LAB 134221
10 XBRL PRESENTATION FILE pvct-20180630_pre.xml EX-101.PRE 100118
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36457 | Film No.: 18998851
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences